Erik Harris

Erik Harris

Director/Board Member at REZOLUTE, INC.

Net worth: 3 M $ as of 2026-07-30

56 year
Health Technology
Consumer Services
Commercial Services

Profile

Erik C.
Harris
is an Independent Director at Rezolute, Inc. since 2025, Chief Commercial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. since 2019, and a Trustee at East Bay Zoological Society.
Former roles include Independent Director at Denali Therapeutics, Inc. from 2022 to 2025, Independent Director at Inozyme Pharma, Inc. from 2024 to 2025, Senior Director-Marketing & Sales at Elan Corp.
Plc, Manager-Sales & Marketing at Bristol Myers Squibb Co. from 1999 to 2001, Head-Sales & Marketing at Genentech, Inc. from 2003 to 2007, Vice President-Pulmonology Marketing at InterMune, Inc. from 2009 to 2010, and Vice President-Marketing & Sales at Crescendo Bioscience LLC from 2011 to 2017.
Education includes undergraduate studies at the United States Naval Academy and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-15 118,410 ( 0.12% ) 3 M $ 2026-07-30
2025-11-18 0 ( -.--% ) - $ 2026-07-30

Erik Harris active positions

CompaniesPositionStart
ULTRAGENYX PHARMACEUTICAL INC. Corporate Officer/Principal 2016-12-31
REZOLUTE, INC. Director/Board Member 2025-03-24
Director/Board Member -

Former positions of Erik Harris

CompaniesPositionEnd
INOZYME PHARMA, INC. Director/Board Member 2025-06-30
DENALI THERAPEUTICS INC. Director/Board Member 2025-06-02
Sales & Marketing 2017-05-31
INTERMUNE INC Sales & Marketing 2010-07-31
Corporate Officer/Principal 2006-12-31
See the detail of Erik Harris's experience

Training of Erik Harris

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology